Will Rosen

Experience

• Advised ERM, the world’s largest pure-play sustainability consultancy, and the ERM Partner shareholders, on the sale of ERM to KKR, a leading global investment firm
• Advised Baring Private Equity Asia on the sale of Lumenis LTD. Surgical Business, a company that develops and commercializes energy-based medical solutions, to Boston Scientific
• Advised Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on the £167 million acquisition of Praha Vaccines a.s., part of the Cyrus Poonawalla Group
• Advised Envision Pharma Group, a portfolio company of GHO Capital Partners, on its acquisition of Two Labs, an industry-leading provider of integrated and customized commercial solutions to the pharmaceutical and biotechnology sector 
• Advised Advent International on its agreement to acquire Nielsen Global Connect, a unit of Nielsen Holdings plc, for $2.7 billion 
• Advised GHO Capital Partners on its acquisition (alongside the existing Envision management team and employees) of a majority stake in Envision Pharma Group, a leading technology-enabled scientific communications company
• Advised Averna Capital on its investment in ClimateCare, a leading profit with purpose environmental and social impact company headquartered in Oxford, UK
• Advised the Asset Management & Investor Services Divisions of Mitsubishi UFJ Trust and Banking Corporation on its acquisition of Point Nine Limited
• Acting for Bain Capital in connection with its:
• purchase of a controlling stake in MKM, the UK's largest independent builders' merchant, from 3i and Lloyds Development Capital.
• acquisition of NGA UK, a UK payroll and HR Business from NGA Human Resources.
• acquisition of the Ibstock, Forticrete, Supreme and Glen Gery clay and concrete businesses of CRH plc.
• acquisition of TI Automotive.
• Acting for Baring Private Equity Asia in connection with its:
• US$1 billion+ acquisition of Lumenis, the Israeli-headquartered global leader in the field of minimally-invasive clinical solutions for the aesthetic, surgical and ophthalmology specialties
• joint acquisition with PAI Partners of World Freight Company International, the global leader in the General Sales and Service Agent market.
• US$1.8 billion sale, alongside the Shanghai-based Bright Food Group, of British breakfast  cereal brand Weetabix to U.S.-based cereal company, Post Holdings.
• Represented Marquee Brands LLC in its acquisition of British men's clothing brand Ben Sherman and its related intellectual property assets from Oxford Industries, Inc. 
• Acting for Kanders & Company and its portfolio company The Safariland Group, on the acquisition of the Med-Eng explosive ordinance disposal and crew survivability businesses from the Allen-Vanguard Corporation.
• Acting for Summit Partners in connection with its:
• disposal of the entire issued share capital of Actix International Limited to Amdocs Limited.
• joint venture with FleetCor to acquire UK-based Masternaut from Francisco Partners.
• Acting for Wright Medical Technology, Inc. on its US$3.3 billion merger with Tornier N.V.
• Acting for Smedvig Capital in connection with its
• sale of Ocean Outdoor to Lloyds Development Capital and acting for management in the subsequent sales to Searchlight Capital.
• sale of Tuskerdirect Limited to ECI Partners LLP.
• Acting for Oxford Immunotec Global plc on its listing on the NASDAQ Global Market.
• Acting for PERE Fund on the sale of Executive Offices Group for £260 million to Queensgate Investments.

Disclaimer

Ropes & Gray International LLP is a limited liability partnership registered in Delaware, United States of America and is a recognised body regulated by the Solicitors Regulation Authority (with registered number 521000).